PepGen Inc.
PEPG
$2.40
$0.1456.44%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/14/2025
-
MarketBeat
3/10/2025
-
GuruFocus
3/10/2025
-
Business Wire
3/7/2025
-
Ticker Report
3/7/2025
-
MarketBeat
3/4/2025
-
Benzinga
3/4/2025
-
Simply Wall St
3/4/2025
-
GuruFocus
3/4/2025
-
GuruFocus
3/4/2025
-
Seeking Alpha - Healthcare
3/4/2025
-
TipRanks Financial Blog
3/4/2025
-
Business Wire
3/4/2025
-
The Fly
3/4/2025
-
Business Wire
3/3/2025
-
Stocktwits News Feed
2/28/2025
-
Stocktwits News Feed
2/26/2025
-
MarketBeat
2/26/2025
-
MarketBeat
2/26/2025
-
GuruFocus
2/26/2025
-
MarketBeat
2/24/2025
-
Stock Options Channel
2/24/2025
-
MarketBeat
2/24/2025
-
The Fly
2/24/2025
-
The Fly
2/24/2025
-
Ticker Report
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, February 24, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
781 797 0979
Address
321 Harrison Avenue
Boston, MA 02118
Boston, MA 02118
Country
Year Founded
Business Description
Sector
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. Its lead product...
more
